David Paniagua, MD
See Publications

Texas Heart Institute Positions

  • Teaching Staff, Cardiovascular Disease Fellowship

Education

  • Medical School:

    Universidad de Costa Rica Faculty of Medicine

  • Residency:

    Mount Sinai Medical Center of Florida

  • Fellowships:

    Mount Sinai Medical Center of Florida

Academic & Clinical Affiliations

Publications

4862227 MGN9A7SF 1 alternatives-to-animal-experimentation 10 date desc Paniagua 2042 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22MJXQP2ZT%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Paniagua%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BPaniagua%26lt%3B%5C%2Fstrong%26gt%3B%2C%20D.%2C%20Levine%2C%20G.%20N.%2C%20Cornwell%2C%20L.%20D.%20et%20al.%20%282022%29.%20Decongestion%20models%20and%20metrics%20in%20acute%20heart%20failure%3A%20ESCAPE%20data%20in%20the%20age%20of%20the%20implantable%20cardiac%20pressure%20monitor.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B49%26lt%3B%5C%2Fi%26gt%3B%2C%20e217587.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-21-7587%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-21-7587%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Decongestion%20models%20and%20metrics%20in%20acute%20heart%20failure%3A%20ESCAPE%20data%20in%20the%20age%20of%20the%20implantable%20cardiac%20pressure%20monitor%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Paniagua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Glenn%20N.%22%2C%22lastName%22%3A%22Levine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorraine%20D.%22%2C%22lastName%22%3A%22Cornwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernesto%22%2C%22lastName%22%3A%22Jimenez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biswajit%22%2C%22lastName%22%3A%22Kar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%20E.%22%2C%22lastName%22%3A%22Denktas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tony%20S.%22%2C%22lastName%22%3A%22Ma%22%7D%5D%2C%22abstractNote%22%3A%22The%20United%20States%20Food%20and%20Drug%20Administration%20restricts%20the%20use%20of%20implantable%20cardiac%20pressure%20monitors%20to%20patients%20with%20New%20York%20Heart%20Association%20%28NYHA%29%20class%20III%20heart%20failure%20%28HF%29.%20We%20investigated%20whether%20single-pressure%20monitoring%20could%20predict%20survival%20in%20HF%20patients%20as%20part%20of%20a%20model%20constructed%20using%20data%20from%20the%20ESCAPE%20%28Evaluation%20Study%20of%20Congestive%20Heart%20Failure%20and%20Pulmonary%20Artery%20Catheterization%20Effectiveness%29%20trial.%20We%20validated%20survival%20models%20in%20204%20patients%2C%20using%20all-cause%20180-day%20mortality.%20Two%20levels%20of%20model%20complexity%20were%20tested%3A%201%29%20a%20simplified%201-pressure%20model%20based%20on%20pulmonary%20artery%20mean%20pressure%20%28%5BPAM%5D1P%29%20%28information%20obtainable%20from%20an%20implanted%20intracardiac%20monitor%20alone%29%2C%20and%202%29%20a%20pair%20of%205-variable%20risk%20score%20models%20based%20on%20right%20atrial%20pressure%20%28RAP%29%20%2B%20pulmonary%20capillary%20wedge%20pressure%20%28PCWP%29%20%28%5BRAP%2BPCWP%5D5V%29%20and%20on%20RAP%20%2B%20PAM%20%28%5BRAP%2BPAM%5D5V%29.%20The%20more%20complex%20models%20used%205%20dichotomous%20variables%3A%20a%20congestion%20index%20above%20a%20certain%20threshold%20value%2C%20baseline%20systolic%20blood%20pressure%20of%20%26lt%3B100%20mmHg%2C%20baseline%20blood%20urea%20nitrogen%20level%20of%20%5Cu2265%2034%20mg%5C%2FdL%2C%20need%20for%20cardiopulmonary%20resuscitation%20or%20mechanical%20ventilation%2C%20and%20posttreatment%20NYHA%20class%20IV%20status.%20The%20congestion%20index%20was%20defined%20as%20posttreatment%20RAP%2BPCWP%20or%20posttreatment%20RAP%2BPAM%2C%20with%20congestion%20thresholds%20of%2034%20and%2042%20mmHg%2C%20respectively%20%28median%20pulmonary%20catheter%20indwelling%20time%2C%201.9%20d%29.%20The%205-variable%20models%20predicted%20survival%20with%20areas%20under%20the%20curve%20of%200.868%20for%20the%20%28RAP%2BPCWP%295V%20model%20and%200.827%20for%20the%20%28RAP%2BPAM%295V%20model%2C%20whereas%20the%201-pressure%20model%20predicted%20survival%20with%20an%20area%20under%20the%20curve%20of%200.718.%20We%20conclude%20that%20decongestion%20as%20determined%20by%20hemodynamic%20assessment%20predicts%20survival%20in%20HF%20patients%20and%20that%20it%20may%20be%20the%20final%20pathway%20for%20treatment%20benefit%20despite%20improvements%20in%20pharmacologic%20intervention%20since%20the%20ESCAPE%20trial.%22%2C%22date%22%3A%22Sept%2001%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-21-7587%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MGN9A7SF%22%2C%22VTWWYEIB%22%5D%2C%22dateModified%22%3A%222022-09-02T20%3A10%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22A5MTQ7MY%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Elbadawi%20et%20al.%22%2C%22parsedDate%22%3A%222021-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BElbadawi%2C%20A.%2C%20Mahmoud%2C%20A.%20A.%2C%20Mahmoud%2C%20K.%20et%20al.%20%282021%29.%20Temporal%20trends%20and%20outcomes%20of%20elective%20thoracic%20aortic%20repair%20and%20acute%20aortic%20syndromes%20in%20bicuspid%20aortic%20valves%3A%20Insights%20from%20a%20national%20database.%20%26lt%3Bi%26gt%3BCardiol%20Ther%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%20531%26%23x2013%3B545.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs40119-021-00237-3%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs40119-021-00237-3%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Temporal%20trends%20and%20outcomes%20of%20elective%20thoracic%20aortic%20repair%20and%20acute%20aortic%20syndromes%20in%20bicuspid%20aortic%20valves%3A%20Insights%20from%20a%20national%20database%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayman%22%2C%22lastName%22%3A%22Elbadawi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmad%20A.%22%2C%22lastName%22%3A%22Mahmoud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karim%22%2C%22lastName%22%3A%22Mahmoud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Islam%20Y.%22%2C%22lastName%22%3A%22Elgendy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohmed%20A.%22%2C%22lastName%22%3A%22Omer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmed%22%2C%22lastName%22%3A%22Elsherbeny%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gbolahan%20O.%22%2C%22lastName%22%3A%22Ogunbayo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20J.%22%2C%22lastName%22%3A%22Cameron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravi%22%2C%22lastName%22%3A%22Ghanta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Paniagua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernesto%22%2C%22lastName%22%3A%22Jimenez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20There%20is%20paucity%20of%20data%20on%20the%20outcomes%20of%20hospitalization%20for%20bicuspid%20aortic%20valve%20%28BAV%29-related%20aortopathies.%5CnMETHODS%3A%20We%20queried%20the%20NIS%20database%20%282012-2016%29%20for%20hospitalizations%20for%20elective%20thoracic%20aortic%20repair%20or%20acute%20aortic%20syndrome%20%28AAS%29%20among%20those%20with%20BAV%20versus%20trileaflet%20aortic%20valve%20%28TAV%29.%5CnRESULTS%3A%20Our%20analysis%20yielded%2038%2C010%20hospitalizations%20for%20elective%20aortic%20repair%2C%20of%20whom%2034.4%25%20had%20BAV%2C%20as%20well%20as%2081%2C875%20hospitalizations%20for%20thoracic%20AAS%2C%20of%20whom%201.1%25%20had%20BAV.%20Hospitalizations%20for%20BAV%20were%20younger%20and%20had%20fewer%20comorbidities%20compared%20with%20their%20TAV%20counterparts.%20The%20number%20of%20hospitalizations%20for%20BAV%20during%20the%20observational%20period%20was%20unchanged.%20After%20propensity%20matching%2C%20elective%20aortic%20repair%20for%20BAV%20was%20associated%20with%20lower%20mortality%20%280.5%25%20versus%201.7%25%2C%20odds%20ratio%20%3D%5Cu20090.28%3B%2095%25%20CI%201.5-0.50%2C%20p%5Cu2009%26lt%3B%5Cu20090.001%29%2C%20use%20of%20mechanical%20circulatory%20support%2C%20acute%20stroke%2C%20and%20shorter%20length%20of%20hospital%20stay%20compared%20with%20TAV.%20After%20propensity%20matching%2C%20AAS%20among%20those%20with%20BAV%20had%20a%20greater%20incidence%20of%20bleeding%20events%2C%20blood%20transfusion%2C%20cardiac%20tamponade%2C%20ventricular%20arrhythmias%2C%20and%20a%20longer%20length%20of%20hospital%20stay%20compared%20with%20TAV.%20Among%20those%20with%20BAV%2C%20predictors%20of%20lower%20mortality%20if%20undergoing%20elective%20aortic%20repair%20included%20larger%20hospitals%20and%20teaching%20hospitals.%20Predictors%20of%20higher%20mortality%20in%20patients%20with%20AAS%20included%20heart%20failure%2C%20chronic%20kidney%20disease%2C%20and%20coronary%20artery%20disease.%5CnCONCLUSION%3A%20Data%20from%20a%20national%20database%20showed%20no%20change%20in%20the%20number%20of%20hospitalizations%20for%20BAV-related%20aortopathy%2C%20with%20relatively%20lower%20incidence%20of%20AAS.%20Compared%20with%20TAV%2C%20elective%20aortic%20repair%20for%20BAV%20is%20associated%20with%20lower%20mortality%2C%20while%20BAV-related%20AAS%20is%20associated%20with%20higher%20in-hospital%20complications.%22%2C%22date%22%3A%22Dec%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs40119-021-00237-3%22%2C%22ISSN%22%3A%222193-8261%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MGN9A7SF%22%2C%22AFDZBLNB%22%5D%2C%22dateModified%22%3A%222021-12-06T20%3A05%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22HPACRUR9%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Patel%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-18%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPatel%2C%20V.%2C%20Jneid%2C%20H.%2C%20Cornwell%2C%20L.%20et%20al.%20%282021%29.%20Left%20ventricle%20mass%20regression%20after%20surgical%20or%20transcatheter%20aortic%20valve%20replacement%20in%20veterans.%20%26lt%3Bi%26gt%3BAnn%20Thorac%20Surg%26lt%3B%5C%2Fi%26gt%3B%2C%20S0003-4975%2821%2901429%26%23x2013%3B6.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.athoracsur.2021.07.039%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.athoracsur.2021.07.039%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Left%20ventricle%20mass%20regression%20after%20surgical%20or%20transcatheter%20aortic%20valve%20replacement%20in%20veterans%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivek%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorraine%22%2C%22lastName%22%3A%22Cornwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riyad%22%2C%22lastName%22%3A%22Kherallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ourania%22%2C%22lastName%22%3A%22Preventza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arsalan%22%2C%22lastName%22%3A%22Amin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirza%22%2C%22lastName%22%3A%22Khalid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Paniagua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Denktas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashley%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22McClafferty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernesto%22%2C%22lastName%22%3A%22Jimenez%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Differences%20in%20left%20ventricular%20mass%20regression%20%28LVMR%29%20between%20transcatheter%20aortic%20valve%20replacement%20%28TAVR%29%20and%20surgical%20aortic%20valve%20replacement%20%28SAVR%29%20have%20not%20been%20studied.%20We%20present%20clinical%20and%20echocardiographic%20data%20from%20veterans%20who%20underwent%20TAVR%20and%20SAVR%2C%20evaluating%20the%20degree%20of%20LVMR%20and%20its%20association%20with%20survival.%5CnMETHODS%3A%20We%20retrospectively%20reviewed%20TAVR%20%28n%5Cu00a0%3D%20194%29%20and%20SAVR%20%28n%5Cu00a0%3D%20365%29%20procedures%20performed%20in%20veterans%20from%202011%20to%202019.%20After%201%3A1%20propensity%20matching%2C%20we%20evaluated%20mortality%20and%20secondary%20outcomes.%20Echocardiographic%20data%20%28median%20follow-up%20957%20days%2C%20interquartile%20range%20483-1652%20days%29%20were%20used%20to%20evaluate%20LVMR%2C%20its%20association%20with%20survival%2C%20and%20predictors%20of%20LVMR.%5CnRESULTS%3A%20There%20was%20no%20difference%20between%20SAVR%20and%20TAVR%20patients%20in%20mortality%20%28for%20up%20to%208%20years%29%2C%20stroke%20at%2030%20days%2C%20myocardial%20infarction%2C%20renal%20failure%2C%20prolonged%20ventilation%2C%20reoperation%2C%20or%20structural%20valve%20deterioration.%20SAVR%20patients%20%2867.3%25%20%5B101%20of%20150%5D%29%20were%20more%20likely%20to%20have%20LVMR%20than%20TAVR%20patients%20%2855.7%25%20%5B44%20of%2079%5D%2C%20P%5Cu00a0%3D%20.11%29.%20The%20magnitude%20of%20LVMR%20was%20greater%20for%20the%20SAVR%20patients%20%28median%2C%5Cu00a0-23.3%25%29%20than%20for%20the%20TAVR%20patients%20%28median%2C%5Cu00a0-17.8%25%2C%20P%5Cu00a0%3D%20.062%29.%20SAVR%20patients%20with%20LVMR%20had%20a%20survival%20advantage%20over%20SAVR%20patients%20without%20LVMR%20%28P%5Cu00a0%3D%20.016%29.%20However%2C%20LVMR%20was%20not%20associated%20with%20greater%20survival%20in%20TAVR%20patients%20%28P%5Cu00a0%3D%20.248%29.%5CnCONCLUSIONS%3A%20SAVR%20patients%20were%20more%20likely%20to%20have%20LVMR%20and%20had%20a%20greater%20magnitude%20of%20LVMR%20than%20TAVR%20patients.%20LVMR%20was%20associated%20with%20better%20survival%20in%20SAVR%20patients%2C%20but%20not%20in%20TAVR%20patients.%22%2C%22date%22%3A%22Aug%2018%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.athoracsur.2021.07.039%22%2C%22ISSN%22%3A%221552-6259%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SQD2CTYV%22%2C%22MGN9A7SF%22%2C%22BCTBZ4XB%22%2C%22UWTRFEPH%22%5D%2C%22dateModified%22%3A%222021-12-06T20%3A01%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22I8JEIZUB%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Patel%20et%20al.%22%2C%22parsedDate%22%3A%222020-07-07%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPatel%2C%20V.%2C%20Jimenez%2C%20E.%2C%20Cornwell%2C%20L.%20et%20al.%20%282020%29.%20Cardiac%20surgery%20during%20the%20coronavirus%20disease%202019%20pandemic%3A%20Perioperative%20considerations%20and%20triage%20recommendations.%20%26lt%3Bi%26gt%3BJ%20Am%20Heart%20Assoc%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B%2C%20e017042.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FJAHA.120.017042%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FJAHA.120.017042%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cardiac%20surgery%20during%20the%20coronavirus%20disease%202019%20pandemic%3A%20Perioperative%20considerations%20and%20triage%20recommendations%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivek%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernesto%22%2C%22lastName%22%3A%22Jimenez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorraine%22%2C%22lastName%22%3A%22Cornwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trung%22%2C%22lastName%22%3A%22Tran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Paniagua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%20E.%22%2C%22lastName%22%3A%22Denktas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Chou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%20J.%22%2C%22lastName%22%3A%22Hankins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biykem%22%2C%22lastName%22%3A%22Bozkurt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%5D%2C%22abstractNote%22%3A%22The%20coronavirus%20disease%202019%20pandemic%2C%20caused%20by%20severe%20acute%20respiratory%20syndrome%20coronavirus-2%2C%20represents%20the%20third%20human%20affliction%20attributed%20to%20the%20highly%20pathogenic%20coronavirus%20in%20the%20current%20century.%20Because%20of%20its%20highly%20contagious%20nature%20and%20unprecedented%20global%20spread%2C%20its%20aggressive%20clinical%20presentation%2C%20and%20the%20lack%20of%20effective%20treatment%2C%20severe%20acute%20respiratory%20syndrome%20coronavirus-2%20infection%20is%20causing%20the%20loss%20of%20thousands%20of%20lives%20and%20imparting%20unparalleled%20strain%20on%20healthcare%20systems%20around%20the%20world.%20In%20the%20current%20report%2C%20we%20discuss%20perioperative%20considerations%20for%20patients%20undergoing%20cardiac%20surgery%20and%20provide%20clinicians%20with%20recommendations%20to%20effectively%20triage%20and%20plan%20these%20procedures%20during%20the%20coronavirus%20disease%202019%20outbreak.%20This%20will%20help%20reduce%20the%20risk%20of%20exposure%20to%20patients%20and%20healthcare%20workers%20and%20allocate%20resources%20appropriately%20to%20those%20in%20greatest%20need.%20We%20include%20an%20algorithm%20for%20preoperative%20testing%20for%20coronavirus%20disease%202019%2C%20personal%20protective%20equipment%20recommendations%2C%20and%20a%20classification%20system%20to%20categorize%20and%20prioritize%20common%20cardiac%20surgery%20procedures.%22%2C%22date%22%3A%22Jul%2007%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FJAHA.120.017042%22%2C%22ISSN%22%3A%222047-9980%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%224SHBB8V2%22%2C%22MGN9A7SF%22%2C%22BCTBZ4XB%22%2C%22GL8QP2FN%22%5D%2C%22dateModified%22%3A%222023-01-12T21%3A56%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22JCC54CPN%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Quintana%20et%20al.%22%2C%22parsedDate%22%3A%222020-02-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BQuintana%2C%20R.%20A.%2C%20Monlezun%2C%20D.%20J.%2C%20Davogustto%2C%20G.%20et%20al.%20%282020%29.%20Outcomes%20following%20percutaneous%20coronary%20intervention%20in%20patients%20with%20cancer.%20%26lt%3Bi%26gt%3BInt%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B300%26lt%3B%5C%2Fi%26gt%3B%2C%20106%26%23x2013%3B112.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcard.2019.09.016%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcard.2019.09.016%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Outcomes%20following%20percutaneous%20coronary%20intervention%20in%20patients%20with%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymundo%20A.%22%2C%22lastName%22%3A%22Quintana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%20J.%22%2C%22lastName%22%3A%22Monlezun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%22%2C%22lastName%22%3A%22Davogustto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Humberto%20R.%22%2C%22lastName%22%3A%22Saenz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francisco%22%2C%22lastName%22%3A%22Lozano-Ruiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisuke%22%2C%22lastName%22%3A%22Sueta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenichi%22%2C%22lastName%22%3A%22Tsujita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uri%22%2C%22lastName%22%3A%22Landes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%20E.%22%2C%22lastName%22%3A%22Denktas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahboob%22%2C%22lastName%22%3A%22Alam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Paniagua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Addison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Randomized%20clinical%20trials%20demonstrated%20the%20benefits%20of%20percutaneous%20coronary%20interventions%20%28PCI%29%20in%20diverse%20clinical%20settings.%20Patients%20with%20cancer%20were%20not%20routinely%20included%20in%20these%20studies.%5CnMETHODS%5C%2FRESULTS%3A%20Literature%20search%20of%20PubMed%2C%20Cochrane%2C%20Medline%2C%20SCOPUS%2C%20EMBASE%2C%20and%20ClinicalTrials%20was%20conducted%20to%20identify%20studies%20that%20assessed%20one-year%20all-cause%2C%20cardiovascular%20and%20non-cardiovascular%20mortality%20in%20patients%20with%20historical%20or%20active%20cancer.%20Using%20the%20random%20effects%20model%2C%20we%20computed%20risk%20ratios%20%28RRs%29%20and%20standardized%20mean%20differences%20and%20their%2095%25%20confidence%20intervals%20for%20the%20dichotomous%20and%20continuous%20measures%20and%20outcomes%2C%20respectively.%20Of%20171%20articles%20evaluated%20in%20total%2C%205%20eligible%20studies%20were%20included%20in%20this%20meta-analysis.%20In%20total%2C%2033%2C175%20patients%20receiving%20PCI%20were%20analyzed%2C%20of%20whom%203323%20patients%20had%20cancer%20and%2029%2C852%20no%20cancer%20history.%20Patients%20in%20the%20cancer%20group%20had%20greater%20all-cause%20mortality%20%5BRR%202.22%20%281.51-3.26%3B%20p%26lt%3B0.001%29%5D%2C%20including%20cardiovascular%20mortality%20%5BRR%201.34%20%281.1-1.65%3B%20p%3D0.005%29%5D%20and%20non-cardiovascular%20mortality%20%5BRR%203.42%20%281.74-6.74%3B%20p%5Cu22640.001%5D%2C%20at%20one-year%20compared%20to%20non-cancer%20patients.%20Patients%20in%20the%20cancer%20group%20had%20greater%20one-month%20all-cause%20mortality%20%5BRR%202.01%20%281.24-3.27%3B%20p%3D0.005%29%5D%20and%20greater%20non-cardiovascular%20mortality%20%5BRR%206.87%20%283.10-15.21%3B%20p%5Cu22640.001%29%5D%2C%20but%20no%20difference%20in%20one-month%20cardiovascular%20mortality%20compared%20to%20non-cancer%20patients.%20Meta-regression%20analyses%20showed%20that%20the%20difference%20in%20one-year%20all-cause%20and%20cardiovascular%20mortality%20between%20both%20groups%20was%20not%20attributable%20to%20differences%20in%20baseline%20characteristics%2C%20index%20PCI%20characteristics%2C%20or%20medications%20prescribed%20at%20discharge.%5CnCONCLUSIONS%3A%20Patients%20with%20cancer%20undergoing%20PCI%20have%20worse%20mid-term%20outcomes%20compared%20to%20non-cancer%20patients.%20Cancer%20patients%20should%20be%20managed%20by%20a%20multi-specialist%20team%2C%20in%20an%20effort%20to%20close%20the%20mortality%20gap.%22%2C%22date%22%3A%22Feb%2001%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijcard.2019.09.016%22%2C%22ISSN%22%3A%221874-1754%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZL4RPFGU%22%2C%22MGN9A7SF%22%5D%2C%22dateModified%22%3A%222020-02-07T15%3A58%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22KDN6599M%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Thamwiwat%20et%20al.%22%2C%22parsedDate%22%3A%222018-12-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BThamwiwat%2C%20A.%2C%20Sudhakar%2C%20D.%2C%20%26lt%3Bstrong%26gt%3BPaniagua%26lt%3B%5C%2Fstrong%26gt%3B%2C%20D.%20et%20al.%20%282018%29.%20Suspected%20coronary%20fat%20embolism%20after%20liposuction.%20%26lt%3Bi%26gt%3BCatheter%20Cardiovasc%20Interv%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B92%26lt%3B%5C%2Fi%26gt%3B%2C%20E449%26%23x2013%3BE452.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fccd.27598%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fccd.27598%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Suspected%20coronary%20fat%20embolism%20after%20liposuction%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alisa%22%2C%22lastName%22%3A%22Thamwiwat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepthi%22%2C%22lastName%22%3A%22Sudhakar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Paniagua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%20E.%22%2C%22lastName%22%3A%22Denktas%22%7D%5D%2C%22abstractNote%22%3A%22A%2038-year-old%20female%20presented%20with%20chest%20pain%20and%20ST%20elevation%20on%20electrocardiogram%20after%20an%20outpatient%20liposuction%20procedure.%20Emergent%20coronary%20angiography%20revealed%20complete%20occlusion%20of%20multiple%20coronary%20arteries%2C%20with%20fat%20embolism%20as%20the%20suspected%20etiology.%20Attempts%20to%20restore%20distal%20coronary%20flow%20with%20balloon%20dilatation%2C%20aspiration%20with%20Pronto%20catheter%2C%20and%20distal%20adenosine%20administration%20resulted%20in%20minimal%20improvement%20in%20flow.%20The%20material%20aspirated%20was%20consistent%20with%20fat.%20With%20supportive%20therapy%2C%20including%20Impella%20CP%20support%2C%20the%20patient%26%23039%3Bs%20clinical%20condition%20improved.%20To%20our%20knowledge%2C%20this%20is%20the%20first%20reported%20case%20of%20multiple%20coronary%20occlusion%20after%20liposuction.%22%2C%22date%22%3A%22Dec%2001%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fccd.27598%22%2C%22ISSN%22%3A%221522-726X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MGN9A7SF%22%5D%2C%22dateModified%22%3A%222019-01-04T21%3A48%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22Q6WIVAZZ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brilakis%20et%20al.%22%2C%22parsedDate%22%3A%222018-05-19%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrilakis%2C%20E.%20S.%2C%20Edson%2C%20R.%2C%20Bhatt%2C%20D.%20L.%20et%20al.%20%282018%29.%20Drug-eluting%20stents%20versus%20bare-metal%20stents%20in%20saphenous%20vein%20grafts%3A%20a%20double-blind%2C%20randomised%20trial.%20%26lt%3Bi%26gt%3BLancet%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B391%26lt%3B%5C%2Fi%26gt%3B%2C%201997%26%23x2013%3B2007.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS0140-6736%2818%2930801-8%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS0140-6736%2818%2930801-8%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Drug-eluting%20stents%20versus%20bare-metal%20stents%20in%20saphenous%20vein%20grafts%3A%20a%20double-blind%2C%20randomised%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanouil%20S.%22%2C%22lastName%22%3A%22Brilakis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Edson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepak%20L.%22%2C%22lastName%22%3A%22Bhatt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Goldman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20R.%22%2C%22lastName%22%3A%22Holmes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunil%20V.%22%2C%22lastName%22%3A%22Rao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kendrick%22%2C%22lastName%22%3A%22Shunk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bavana%20V.%22%2C%22lastName%22%3A%22Rangan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kreton%22%2C%22lastName%22%3A%22Mavromatis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kodangudi%22%2C%22lastName%22%3A%22Ramanathan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%20A.%22%2C%22lastName%22%3A%22Bavry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Santiago%22%2C%22lastName%22%3A%22Garcia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%22%2C%22lastName%22%3A%22Latif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ehrin%22%2C%22lastName%22%3A%22Armstrong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20A.%22%2C%22lastName%22%3A%22Conner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%22%2C%22lastName%22%3A%22Wagner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judit%22%2C%22lastName%22%3A%22Karacsonyi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%22%2C%22lastName%22%3A%22Uyeda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Ventura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%22%2C%22lastName%22%3A%22Alsleben%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ying%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mei-Chiung%22%2C%22lastName%22%3A%22Shih%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhash%22%2C%22lastName%22%3A%22Banerjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22DIVA%20Trial%20Investigators%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Few%20studies%20have%20examined%20the%20efficacy%20of%20drug-eluting%20stents%20%28DES%29%20for%20reducing%20aortocoronary%20saphenous%20vein%20bypass%20graft%20%28SVG%29%20failure%20compared%20with%20bare-metal%20stents%20%28BMS%29%20in%20patients%20undergoing%20stenting%20of%20de-novo%20SVG%20lesions.%20We%20assessed%20the%20risks%20and%20benefits%20of%20the%20use%20of%20DES%20versus%20BMS%20in%20de-novo%20SVG%20lesions.%5CnMETHODS%3A%20Patients%20were%20recruited%20to%20our%20double-blind%2C%20randomised%20controlled%20trial%20from%2025%20US%20Department%20of%20Veterans%20Affairs%20centres.%20Eligible%20participants%20were%20aged%20at%20least%2018%20years%20and%20had%20at%20least%20one%20significant%20de-novo%20SVG%20lesion%20%2850-99%25%20stenosis%20of%20a%202%5Cu00b725-4%5Cu00b75%20mm%20diameter%20SVG%29%20requiring%20percutaneous%20coronary%20intervention%20with%20intent%20to%20use%20embolic%20protection%20devices.%20Enrolled%20patients%20were%20randomly%20assigned%2C%20in%20a%201%3A1%20ratio%2C%20by%20phone%20randomisation%20system%20to%20receive%20a%20DES%20or%20BMS.%20Randomisation%20was%20stratified%20by%20presence%20or%20absence%20of%20diabetes%20and%20number%20of%20target%20SVG%20lesions%20requiring%20percutaneous%20coronary%20intervention%20%28one%20or%20two%20or%20more%29%20within%20each%20participating%20site%20by%20use%20of%20an%20adaptive%20scheme%20intended%20to%20balance%20the%20two%20stent%20type%20groups%20on%20marginal%20totals%20for%20the%20stratification%20factors.%20Patients%2C%20referring%20physicians%2C%20study%20coordinators%2C%20and%20outcome%20assessors%20were%20masked%20to%20group%20allocation.%20The%20primary%20endpoint%20was%20the%2012-month%20incidence%20of%20target%20vessel%20failure%2C%20defined%20as%20the%20composite%20of%20cardiac%20death%2C%20target%20vessel%20myocardial%20infarction%2C%20or%20target%20vessel%20revascularisation.%20The%20DIVA%20trial%20is%20registered%20with%20ClinicalTrials.gov%2C%20number%20NCT01121224.%5CnFINDINGS%3A%20Between%20Jan%201%2C%202012%2C%20and%20Dec%2031%2C%202015%2C%20599%20patients%20were%20randomly%20assigned%20to%20the%20stent%20groups%2C%20and%20the%20data%20for%20597%20patients%20were%20used.%20The%20patients%26%23039%3B%20mean%20age%20was%2068%5Cu00b76%20%28SD%207%5Cu00b76%29%20years%2C%20and%20595%20%28%26gt%3B99%25%29%20patients%20were%20men.%20The%20two%20stent%20groups%20were%20similar%20for%20most%20baseline%20characteristics.%20At%2012%20months%2C%20the%20incidence%20of%20target%20vessel%20failure%20was%2017%25%20%2851%20of%20292%29%20in%20the%20DES%20group%20versus%2019%25%20%2858%20of%20305%29%20in%20the%20BMS%20group%20%28adjusted%20hazard%20ratio%200%5Cu00b792%2C%2095%25%20CI%200%5Cu00b763-1%5Cu00b734%2C%20p%3D0%5Cu00b770%29.%20Between-group%20differences%20in%20the%20components%20of%20the%20primary%20endpoint%2C%20serious%20adverse%20events%2C%20or%20stent%20thrombosis%20were%20not%20significant.%20Enrolment%20was%20stopped%20before%20the%20revised%20target%20sample%20size%20of%20762%20patients%20was%20reached.%5CnINTERPRETATION%3A%20In%20patients%20undergoing%20stenting%20of%20de-novo%20SVG%20lesions%2C%20no%20significant%20differences%20in%20outcomes%20between%20those%20receiving%20DES%20and%20BMS%20during%2012%20months%20of%20follow-up%20were%20found.%20The%20study%20results%20have%20important%20economic%20implications%20in%20countries%20with%20high%20DES%20prices%20such%20as%20the%20USA%2C%20because%20they%20suggest%20that%20the%20lower-cost%20BMS%20can%20be%20used%20in%20SVG%20lesions%20without%20compromising%20either%20safety%20or%20efficacy.%5CnFUNDING%3A%20US%20Department%20of%20Veterans%20Affairs%20Cooperative%20Studies%20Program.%22%2C%22date%22%3A%22May%2019%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS0140-6736%2818%2930801-8%22%2C%22ISSN%22%3A%221474-547X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MGN9A7SF%22%5D%2C%22dateModified%22%3A%222019-01-04T21%3A58%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22ZFR6BMJD%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Weisbord%20et%20al.%22%2C%22parsedDate%22%3A%222018-02-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWeisbord%2C%20S.%20D.%2C%20Gallagher%2C%20M.%2C%20Jneid%2C%20H.%20et%20al.%20%282018%29.%20Outcomes%20after%20Angiography%20with%20Sodium%20Bicarbonate%20and%20Acetylcysteine.%20%26lt%3Bi%26gt%3BN%20Engl%20J%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B378%26lt%3B%5C%2Fi%26gt%3B%2C%20603%26%23x2013%3B614.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa1710933%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa1710933%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Outcomes%20after%20Angiography%20with%20Sodium%20Bicarbonate%20and%20Acetylcysteine%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20D.%22%2C%22lastName%22%3A%22Weisbord%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Gallagher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Santiago%22%2C%22lastName%22%3A%22Garcia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%22%2C%22lastName%22%3A%22Cass%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Soe-Soe%22%2C%22lastName%22%3A%22Thwin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20A.%22%2C%22lastName%22%3A%22Conner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Glenn%20M.%22%2C%22lastName%22%3A%22Chertow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepak%20L.%22%2C%22lastName%22%3A%22Bhatt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kendrick%22%2C%22lastName%22%3A%22Shunk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chirag%20R.%22%2C%22lastName%22%3A%22Parikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20O.%22%2C%22lastName%22%3A%22McFalls%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%22%2C%22lastName%22%3A%22Brophy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22Ferguson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hongsheng%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Androsenko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Myles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Kaufman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20M.%22%2C%22lastName%22%3A%22Palevsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22PRESERVE%20Trial%20Group%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Intravenous%20sodium%20bicarbonate%20and%20oral%20acetylcysteine%20are%20widely%20used%20to%20prevent%20acute%20kidney%20injury%20and%20associated%20adverse%20outcomes%20after%20angiography%20without%20definitive%20evidence%20of%20their%20efficacy.%5CnMETHODS%3A%20Using%20a%202-by-2%20factorial%20design%2C%20we%20randomly%20assigned%205177%20patients%20at%20high%20risk%20for%20renal%20complications%20who%20were%20scheduled%20for%20angiography%20to%20receive%20intravenous%201.26%25%20sodium%20bicarbonate%20or%20intravenous%200.9%25%20sodium%20chloride%20and%205%20days%20of%20oral%20acetylcysteine%20or%20oral%20placebo%3B%20of%20these%20patients%2C%204993%20were%20included%20in%20the%20modified%20intention-to-treat%20analysis.%20The%20primary%20end%20point%20was%20a%20composite%20of%20death%2C%20the%20need%20for%20dialysis%2C%20or%20a%20persistent%20increase%20of%20at%20least%2050%25%20from%20baseline%20in%20the%20serum%20creatinine%20level%20at%2090%20days.%20Contrast-associated%20acute%20kidney%20injury%20was%20a%20secondary%20end%20point.%5CnRESULTS%3A%20The%20sponsor%20stopped%20the%20trial%20after%20a%20prespecified%20interim%20analysis.%20There%20was%20no%20interaction%20between%20sodium%20bicarbonate%20and%20acetylcysteine%20with%20respect%20to%20the%20primary%20end%20point%20%28P%3D0.33%29.%20The%20primary%20end%20point%20occurred%20in%20110%20of%202511%20patients%20%284.4%25%29%20in%20the%20sodium%20bicarbonate%20group%20as%20compared%20with%20116%20of%202482%20%284.7%25%29%20in%20the%20sodium%20chloride%20group%20%28odds%20ratio%2C%200.93%3B%2095%25%20confidence%20interval%20%5BCI%5D%2C%200.72%20to%201.22%3B%20P%3D0.62%29%20and%20in%20114%20of%202495%20patients%20%284.6%25%29%20in%20the%20acetylcysteine%20group%20as%20compared%20with%20112%20of%202498%20%284.5%25%29%20in%20the%20placebo%20group%20%28odds%20ratio%2C%201.02%3B%2095%25%20CI%2C%200.78%20to%201.33%3B%20P%3D0.88%29.%20There%20were%20no%20significant%20between-group%20differences%20in%20the%20rates%20of%20contrast-associated%20acute%20kidney%20injury.%5CnCONCLUSIONS%3A%20Among%20patients%20at%20high%20risk%20for%20renal%20complications%20who%20were%20undergoing%20angiography%2C%20there%20was%20no%20benefit%20of%20intravenous%20sodium%20bicarbonate%20over%20intravenous%20sodium%20chloride%20or%20of%20oral%20acetylcysteine%20over%20placebo%20for%20the%20prevention%20of%20death%2C%20need%20for%20dialysis%2C%20or%20persistent%20decline%20in%20kidney%20function%20at%2090%20days%20or%20for%20the%20prevention%20of%20contrast-associated%20acute%20kidney%20injury.%20%28Funded%20by%20the%20U.S.%20Department%20of%20Veterans%20Affairs%20Office%20of%20Research%20and%20Development%20and%20the%20National%20Health%20and%20Medical%20Research%20Council%20of%20Australia%3B%20PRESERVE%20ClinicalTrials.gov%20number%2C%20NCT01467466%20.%29.%22%2C%22date%22%3A%22Feb%2015%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMoa1710933%22%2C%22ISSN%22%3A%221533-4406%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MGN9A7SF%22%5D%2C%22dateModified%22%3A%222019-01-04T21%3A58%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22QT45E2YM%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Denktas%20et%20al.%22%2C%22parsedDate%22%3A%222017-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDenktas%2C%20A.%20E.%2C%20%26lt%3Bstrong%26gt%3BPaniagua%26lt%3B%5C%2Fstrong%26gt%3B%2C%20D.%20and%20Jneid%2C%20H.%20%282017%29.%20Renal%20denervation%3A%20are%20we%20on%20the%20right%20path%3F%20%26lt%3Bi%26gt%3BCleve%20Clin%20J%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B84%26lt%3B%5C%2Fi%26gt%3B%2C%20687%26%23x2013%3B689.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3949%5C%2Fccjm.84a.17024%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3949%5C%2Fccjm.84a.17024%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Renal%20denervation%3A%20are%20we%20on%20the%20right%20path%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%20E.%22%2C%22lastName%22%3A%22Denktas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Paniagua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Sep%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3949%5C%2Fccjm.84a.17024%22%2C%22ISSN%22%3A%221939-2869%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MGN9A7SF%22%5D%2C%22dateModified%22%3A%222018-05-14T21%3A52%3A37Z%22%7D%7D%2C%7B%22key%22%3A%2275KYE3SP%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Secemsky%20et%20al.%22%2C%22parsedDate%22%3A%222017-05-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSecemsky%2C%20E.%20A.%2C%20Yeh%2C%20R.%20W.%2C%20Kereiakes%2C%20D.%20J.%20et%20al.%20%282017%29.%20Mortality%20Following%20Cardiovascular%20and%20Bleeding%20Events%20Occurring%20Beyond%201%20Year%20After%20Coronary%20Stenting%3A%20A%20Secondary%20Analysis%20of%20the%20Dual%20Antiplatelet%20Therapy%20%28DAPT%29%20Study.%20%26lt%3Bi%26gt%3BJAMA%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B2%26lt%3B%5C%2Fi%26gt%3B%2C%20478%26%23x2013%3B487.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjamacardio.2017.0063%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjamacardio.2017.0063%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mortality%20Following%20Cardiovascular%20and%20Bleeding%20Events%20Occurring%20Beyond%201%20Year%20After%20Coronary%20Stenting%3A%20A%20Secondary%20Analysis%20of%20the%20Dual%20Antiplatelet%20Therapy%20%28DAPT%29%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20A.%22%2C%22lastName%22%3A%22Secemsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20W.%22%2C%22lastName%22%3A%22Yeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dean%20J.%22%2C%22lastName%22%3A%22Kereiakes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donald%20E.%22%2C%22lastName%22%3A%22Cutlip%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20J.%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20Gabriel%22%2C%22lastName%22%3A%22Steg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20P.%22%2C%22lastName%22%3A%22Cannon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%20K.%22%2C%22lastName%22%3A%22Apruzzese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ralph%20B.%22%2C%22lastName%22%3A%22D%27Agostino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20M.%22%2C%22lastName%22%3A%22Massaro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Mauri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Dual%20Antiplatelet%20Therapy%20%28DAPT%29%20Study%20Investigators%22%7D%5D%2C%22abstractNote%22%3A%22Importance%3A%20Early%20cardiovascular%20and%20bleeding%20events%20after%20coronary%20stenting%20are%20associated%20with%20high%20risk%20of%20morbidity%20and%20mortality.%5CnObjective%3A%20To%20assess%20the%20prognosis%20of%20cardiovascular%20and%20bleeding%20events%20occurring%20beyond%201%20year%20after%20coronary%20stenting.%5CnDesign%2C%20Setting%2C%20and%20Participants%3A%20This%20secondary%20analysis%20is%20derived%20from%20data%20from%20the%20Dual%20Antiplatelet%20Therapy%20%28DAPT%29%20Study%2C%20a%20multicenter%20trial%20involving%20220%20US%20and%20international%20clinical%20sites%20from%2011%20countries.%20The%20study%20dates%20were%20August%202009%20to%20May%202014.%20Individuals%20who%20underwent%20coronary%20stenting%20and%20completed%2012%20months%20of%20thienopyridine%20plus%20aspirin%20therapy%20without%20ischemic%20or%20bleeding%20events%20remained%20on%20an%20aspirin%20regimen%20and%20were%20randomized%20to%20continued%20thienopyridine%20therapy%20vs%20placebo%20for%2018%20additional%20months.%20Individuals%20were%20then%20followed%20up%20for%203%20additional%20months%20while%20receiving%20aspirin%20therapy%20alone.%20The%20analysis%20began%20in%20August%202015.%5CnExposures%3A%20Ischemic%20events%20%28myocardial%20infarction%20not%20related%20to%20stent%20thrombosis%2C%20stent%20thrombosis%2C%20and%20ischemic%20stroke%29%20and%20bleeding%20events%20%28Global%20Utilization%20of%20Streptokinase%20and%20Tissue%20Plasminogen%20Activator%20for%20Occluded%20Arteries%20%5BGUSTO%5D%20classification%20moderate%20or%20severe%20bleeding%29.%5CnMain%20Outcomes%20and%20Measures%3A%20Ischemic%20events%20%28myocardial%20infarction%20not%20related%20to%20stent%20thrombosis%2C%20stent%20thrombosis%2C%20and%20ischemic%20stroke%29%20and%20bleeding%20events%20%28GUSTO%20classification%20moderate%20or%20severe%20bleeding%29.%20Death%20at%2021%20months%20after%20randomization%20%2833%20months%20after%20coronary%20stenting%29.%5CnResults%3A%20In%20total%2C%2025%5Cu202f682%20individuals%20older%20than%2018%20years%20with%20an%20indication%20for%20coronary%20stenting%20were%20enrolled%2C%20and%2011%5Cu202f648%20%28mean%20age%2C%2061.3%20years%3B%2025.1%25%20female%29%20were%20randomized.%20After%20randomization%2C%20478%20individuals%20%284.1%25%29%20had%20502%20ischemic%20events%20%28306%20with%20myocardial%20infarction%2C%20113%20with%20stent%20thrombosis%2C%20and%2083%20with%20ischemic%20stroke%29%2C%20and%20232%20individuals%20%282.0%25%29%20had%20235%20bleeding%20events%20%28155%20with%20moderate%20and%2080%20with%20severe%20bleeding%29.%20Among%20individuals%20with%20ischemic%20events%2C%2052%20%2810.9%25%29%20died.%20The%20annualized%20mortality%20rate%20after%20an%20ischemic%20event%20was%2027.2%20%2895%25%20CI%2C%2020.3-35.7%29%20per%20100%20person-years.%20The%20cumulative%20incidence%20of%20death%20after%20an%20ischemic%20event%20among%20the%20total%20randomized%20study%20population%20was%200.5%25%20%280.3%25%20with%20myocardial%20infarction%2C%200.1%25%20with%20stent%20thrombosis%2C%20and%200.1%25%20with%20ischemic%20stroke%29.%20Among%20individuals%20with%20bleeding%20events%2C%2041%20%2817.7%25%29%20died.%20The%20annualized%20mortality%20rate%20after%20a%20bleeding%20event%20was%2021.5%20%2895%25%20CI%2C%2015.4-29.1%29%20per%20100%20person-years.%20The%20cumulative%20incidence%20of%20death%20after%20a%20bleeding%20event%20among%20the%20total%20randomized%20study%20population%20was%200.3%25%20%280.1%25%20with%20moderate%20and%200.2%25%20with%20severe%20bleeding%29.%5CnConclusions%20and%20Relevance%3A%20In%20patients%20treated%20with%20dual%20antiplatelet%20therapy%20for%20at%20least%201%20year%20after%20coronary%20stenting%2C%20ischemic%20events%20were%20more%20frequent%20than%20bleeding%20events%2C%20and%20both%20events%20were%20associated%20with%20high%20risk%20of%20mortality.%5CnTrial%20Registration%3A%20clinicaltrials.gov%20Identifier%3A%20NCT00977938.%22%2C%22date%22%3A%22May%2001%2C%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1001%5C%2Fjamacardio.2017.0063%22%2C%22ISSN%22%3A%222380-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MGN9A7SF%22%5D%2C%22dateModified%22%3A%222019-01-04T21%3A53%3A00Z%22%7D%7D%5D%7D
Paniagua, D., Levine, G. N., Cornwell, L. D. et al. (2022). Decongestion models and metrics in acute heart failure: ESCAPE data in the age of the implantable cardiac pressure monitor. Tex Heart Inst J 49, e217587. https://doi.org/10.14503/THIJ-21-7587.
Elbadawi, A., Mahmoud, A. A., Mahmoud, K. et al. (2021). Temporal trends and outcomes of elective thoracic aortic repair and acute aortic syndromes in bicuspid aortic valves: Insights from a national database. Cardiol Ther 10, 531–545. https://doi.org/10.1007/s40119-021-00237-3.
Patel, V., Jneid, H., Cornwell, L. et al. (2021). Left ventricle mass regression after surgical or transcatheter aortic valve replacement in veterans. Ann Thorac Surg, S0003-4975(21)01429–6. https://doi.org/10.1016/j.athoracsur.2021.07.039.
Patel, V., Jimenez, E., Cornwell, L. et al. (2020). Cardiac surgery during the coronavirus disease 2019 pandemic: Perioperative considerations and triage recommendations. J Am Heart Assoc 9, e017042. https://doi.org/10.1161/JAHA.120.017042.
Quintana, R. A., Monlezun, D. J., Davogustto, G. et al. (2020). Outcomes following percutaneous coronary intervention in patients with cancer. Int J Cardiol 300, 106–112. https://doi.org/10.1016/j.ijcard.2019.09.016.
Thamwiwat, A., Sudhakar, D., Paniagua, D. et al. (2018). Suspected coronary fat embolism after liposuction. Catheter Cardiovasc Interv 92, E449–E452. https://doi.org/10.1002/ccd.27598.
Brilakis, E. S., Edson, R., Bhatt, D. L. et al. (2018). Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial. Lancet 391, 1997–2007. https://doi.org/10.1016/S0140-6736(18)30801-8.
Weisbord, S. D., Gallagher, M., Jneid, H. et al. (2018). Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. N Engl J Med 378, 603–614. https://doi.org/10.1056/NEJMoa1710933.
Denktas, A. E., Paniagua, D. and Jneid, H. (2017). Renal denervation: are we on the right path? Cleve Clin J Med 84, 687–689. https://doi.org/10.3949/ccjm.84a.17024.
Secemsky, E. A., Yeh, R. W., Kereiakes, D. J. et al. (2017). Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study. JAMA Cardiol 2, 478–487. https://doi.org/10.1001/jamacardio.2017.0063.